JOHNSON & JOHNSON — Director's Dealing 2026

Feb 10, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2026-02-06

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-06	Common Stock	M	15571	$101.87	Acquired	32460	Direct
2026-02-06	Common Stock	F	10335	$239.99	Disposed	22125	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-06	Employee Stock Options (Right to Buy)	$101.87	M	15571	Disposed	2026-02-08	Common Stock (15571)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	745	Indirect
Common Stock	46	Indirect

Footnotes

F1: Reflects the auto-exercise of options immediately prior to their expiration.

F2: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).